DatasetName,DSTN_C(25) DSTN_S(155) DSTN_S(24) DSTN_S(3) DSTN_S(71) DSTN_S(88),DSTN_S(12)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.48050778387146154,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,0.4709776861643578,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.47779858485485055,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.47369321999204334,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.4455274165125566,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,0.5219017611365596,
FSO2013_Ratio M/L normalized Rep1,0.44946508162743565,
SR2019_MDAMB231_Biol_repl_4,0.48278023864277914,
GF2025_P2_Sph,0.4710492505225152,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.4808250468957637,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.4499339723995966,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.47907888197574766,
WZ2023_Pu_010_30min,0.4742722764963161,0.9617174688925996
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5277047084931455,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.4785440041667761,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.47365502965930006,
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.45249057506441037,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5076121371035921,
AH2018_SILAC_MR_2_N,0.4713895961720085,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.45417577480321847,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.48366198993701476,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.47824224115939334,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.44325780728983494,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.48284864572542346,0.9675525218134564
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.48483879966395965,
WZ2023_Pu_005_10min,0.49001780348548385,0.974370842057681
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.47309008132624036,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.475195543772506,0.9585602720645284
AH2018_SILAC_MR_2_X,0.5267838487454024,
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4494240935181412,
FR2021_Norm.Intensity.B,0.5074364570742125,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,0.4797550379050855,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.4545747373050935,
CR2017_Ratio Replicate 1.3,,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,0.5094073513401047,
AH2018_SILAC_3_X,0.4637242667879429,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5054124172033916,
HS2024_7_PD_T2,0.4867119435485447,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,0.412080657057532,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.4759985108028721,
HS2024_3_B_N1,0.45549272096795046,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.47812029179603965,0.9676404867018096
CK2022_11 40-1,0.47348299265123184,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5041734300702344,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5090902856526686,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.4703723720748794,0.9646235335250708
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5097699104434597,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.46740152574227717,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,0.5103187241553232,
AH2018_LFQ_M_1_C,0.5259201825670972,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,0.4886587057567171,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.4430951901404569,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,0.48083051118691955,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,0.5049396800483114,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,0.46075364028244525,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.47489919106370154,
CK2022_1 200-1,0.49657223630704594,
PG2020_Intensity Mock_10h_D,0.4678891289339196,
SR2019_MCF10A_Biol_repl_2,0.48229703760563697,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.45470837336601716,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4952279862743385,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.46992077532385546,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,,
PG2020_Intensity 2h_C,0.4617806645092491,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.44253828181614113,
KBE2022_Log2_Ex_8_T,0.475972901706972,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.44084038720544655,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5214716996063772,
CK2022_3 40-1,0.47522949180706603,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.45593980481470003,
YA2020_Reporter_intensity_Cancer_No.5,0.4554299832796381,
HH2022_Reporter intensity 8,,
ZQ2022_N2,0.5032476534103789,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.4752947754441343,
EJN2021_5_Rest_Basal,0.45199156545056524,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.46378207345192574,
YA2020_Reporter_intensity_Normal_No.1,0.4540363949580171,
HS2024_3_B_T1,0.4581385248046661,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.4795158657558843,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.4755834411609305,
HS2024_8_I_T3,,
CF2017_EOC 3,0.4244775840125407,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.4492883675828989,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.5136164381156733,
WZ2023_Pu_010_20min,0.4723836306267562,0.9676901371741464
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.4747003584237124,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.47901598438679877,
KS2014_Intensity N3,0.48821501787860805,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.47954143659868304,
FSO2013_Ratio H/M normalized Rep2,0.47133870873310085,
RAM2015_Log2 A,0.4432585235613564,
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.47838299792537536,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5066442314226424,
HS2024_7_I_T1,0.4810077842583533,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,0.46655426214988266,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.4643701352089655,
AH2018_SILAC_M_3_X,0.4661345204291143,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.47215839587215286,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.48030162901593804,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.47973447659771323,
HS2024_6_B_N1,0.46224421021959056,
KBE2022_Log2_Ex_27_T,0.48556901250788426,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,0.4862701489409759,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5069388446950823,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.48932808840402625,
FSO2013_Ratio M/L normalized Rep2,0.468507766853198,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,0.4724821285048925,
CK2022_14 40-1,0.4739807423285048,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.47004515860196205,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5284031425546593,
DL2023_control-1,,
AR2021_ALG 10 μM,0.48095730570770995,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.4590774853617731,
EJN2021_4_Rest_Ins,0.46506096985903334,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.46556195649638427,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,0.4629186978283011,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.47636721466786064,
JW2021_After_3,,
GF2025_P8_Sph,0.46584302749491363,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5044799210721689,
CK2022_11 200-1,0.49602691493773343,
CK2022_12 200-1,0.4963807776177316,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.47246852788595234,0.9644982947452692
AH2018_TMTMS2_2_N,0.4711627948395835,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.47960816602138373,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.4747970870276086,
KS2014_Intensity N4,0.5011526333200024,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.49789843603058775,
SR2019_Hs578T_Biol_repl_1,0.484180364378199,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.47049815138497625,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.4647123722111924,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,0.4577272724523021,
SR2019_LM2_Biol_repl_4,0.4772754367896319,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.474600745098081,
GF2025_P1_Adh,0.4723097180615658,
GF2025_P1_Sph,0.4657619592566436,
EJN2021_5_Ex_Basal,0.45604254886831147,
HS2024_7_I_T3,0.48938303806522027,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.4929714147381356,0.9671943329564257
CF2017_EOC 1,0.4590072222617352,
CK2022_3 200-1,0.4966829669281548,
AH2018_LFQ_IT_3_C,0.5013947884729973,
SR2019_Hs578T_Biol_repl_2,0.47914172860871834,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.46791245123123365,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,0.4767835279746529,
HS2024_3_B_T2,0.46491518621908395,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.4748493910662452,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.4969193367943974,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.47853465698890885,
AR2021_ALG 1 μM,0.4657232831861713,
HS2024_4_B_T1,0.44607826962189234,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,0.48039453480318106,
EJN2021_1_Rest_Basal,0.45675871249559147,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.477237900886587,
CK2022_9 16-1,0.47567475016318334,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,0.5146835408625535,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.49636079724602394,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.510261872870845,
CK2022_16 16-1,0.4764628099693456,
FS2019_db/db3,0.5291895528550442,
CK2022_15 40-1,0.47423033876258525,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.46766766186578357,0.9586714491376532
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.47744907355353744,
AMK2021_Ctrl_p1,0.5122526850192346,
AH2018_LFQ_IT_3_X,0.5042111878829499,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.48373462764658504,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.4732884630906511,
AH2018_LFQ_M_1_N,0.5193813751340617,
KBE2022_Log2_Ex_27_U,0.48663746139532416,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.48100458366039806,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.4646087944897717,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.47975032270830753,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.47612312656558636,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.47611666497772703,
SR2019_SKBR3_Biol_repl_3,0.48856785527357444,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.44805322562247923,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.4734078225099217,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.4730127004475471,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.45446828900848885,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.4747678287674228,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,0.4777711751851214,
AH2018_TMTMS2_3_X,0.487536727415626,
GF2025_P3_Adh,0.45765293027218074,
SR2019_JIMT1_Biol_repl_2,0.47312447051220924,
AH2018_TMTMS2_1_C,0.46196095047599534,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5172518925036487,
KBE2022_Log2_Ex_19_U,0.4781843119416584,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,0.4633250393763155,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.4682273263478427,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.4680664532954335,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.5255103144870527,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,0.5122526850192346,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5125333418361107,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.4594893203351808,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.45462157386543683,
SR2019_LM2_Biol_repl_3,0.47528283748808603,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.4712935619872008,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.4688662202137713,
AR2021_KD 72h,0.4435798634003462,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.47755353525194283,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.4704735261168816,
KBE2022_Log2_Ex_9_U,0.4727020899839556,
AH2018_SILAC_M_3_N,0.46786339047273223,
KBE2022_Log2_Ex_13_T,0.48074579011779267,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,0.4826840487461182,
PG2020_Intensity Mock_10h_C,0.466677200017206,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.48556662887377167,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.4606265007658308,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,0.507675885269081,
FSO2013_Ratio H/M normalized Rep1___1,0.4711769134895904,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.47685656578150876,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,0.4531368835444989,
TM2022_S2.12h.B,,
RN2012_L15,,
KS2014_Intensity pY_PV3,0.4682288999597424,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.47810794921085176,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.4773351298766959,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5001260230766674,
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.49804302512618653,
CK2022_5 200-1,0.49891189937507724,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5197971474043664,
AH2018_SILAC_MR_1_X,0.521164168246534,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.48055707370364414,
AH2018_SILAC_3_C,0.4606528476594534,
EJN2021_5_Rest_Ins,0.4629053120485715,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,0.46448712448963253,
FSO2013_Ratio H/M normalized Rep1,0.4697170617096574,
CK2022_4 16-1,0.4777002988046237,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.46702940620177985,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5191323874455126,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5024484468124394,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,0.46105051180303125,
KBE2022_Log2_Ex_9_T,0.4737779770340536,
AH2018_SILAC_IT_2_N,0.45891798441037457,
AH2018_SILAC_IT_1_X,0.5039711312575049,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.48392788987835306,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.46581515031669335,
WZ2023_Pe_025_20min,0.48709910993466393,0.967192489365484
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.517991610392574,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.4819241703608203,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.4791823879595754,0.9643893206740064
SR2019_HCC1419_Biol_repl_4,0.47433029534615717,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,0.4752811077192614,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.4889151377689986,
WZ2023_Su_025_10min,0.48487651822517513,0.967585480935536
AH2018_LFQ_IT_4_X,0.46368337055249814,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.463325805641138,0.9535296202724524
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.4837768210142137,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.4729176749676172,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5058729289037092,
LY2019_P7+,0.41744094644550694,
EP2017_Untreated R#1 normalized log2 ratio,0.46704626608860234,
RN2012_L10,,
PG2020_Intensity 4h_C,0.4716143711187624,
EP2017_Mitotic R#3 normalized log2 ratio,0.4942807220122427,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,0.4559290906599438,
KBE2022_Log2_Ex_24_T,0.4740103960651037,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.5068022330362338,
HS2024_4_B_T3,0.4568643769080434,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.4785467804835087,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.49723150126809373,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4824331633609236,
GF2025_P9_Sph,0.4761036389843784,
CK2022_6 200-1,0.49773706542073753,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.4642964181842781,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,0.4551837412097459,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,0.4745796428627758,
HS2024_4_I_T2,0.465290546759113,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.4586924880578205,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,0.47885059108059114,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.4651477794321844,
EP2017_Untreated R#3 normalized log2 ratio,0.4658871319158136,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.49951864334384505,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5130025332922151,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.4824778959124402,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,0.4498614533572549,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5014182703266385,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.4780730450772163,
HS2024_7_I_T2,0.46517185347890755,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,0.47399974746989115,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.462219079367076,
FR2021_Intensity.M,0.5122526850192346,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.5270300409965333,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.44349927425153135,
PG2020_Intensity CT_C,0.47321679322786614,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,0.5194833000007325,
KS2014_Intensity pY_PV4,0.4652658829826563,
KBE2022_Log2_Ex_39_U,0.4821579857124249,
EP2017_Untreated R#3 log2 ratio,0.46664648010942317,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.4812762881546675,
HS2024_8_PD_T2,,
FS2019_Ctr2,0.5189623364425646,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,0.5042148020845798,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.4727801828683786,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.46215387645025324,
YA2020_Reporter_intensity_Normal_No.2,0.4647072566944235,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,0.4604340386819903,
AMK2021_120R_p3,0.5122902918537227,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,0.5086272300040636,
RAM2015_Log2 C,0.4361832106675352,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.5199389628225003,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.47524256490427486,
CK2022_2 16-1,0.47645260791312527,
RAM2015_Log2 B,0.43833098983050894,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,0.4532020042663445,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,0.43341817662198573,
WZ2023_Su_025_30min,0.47276412725751404,0.9488719650236224
AH2018_LFQ_4_N,0.5258959352859288,
CR2017_Ratio Replicate 1.2,,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,0.5013486205998346,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,0.4827921682938319,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.4673719069082794,
DB2022_LFQ intensity R2,0.4579039694408056,
GF2025_P6_Adh,0.46780205711135586,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.4724105880453169,
SR2019_Hs578T_Biol_repl_4,0.47122483024099227,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.47567518204694775,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.45726942432537215,
SR2019_BT549_Biol_repl_1,0.4851044903584598,
AH2018_LFQ_M_4_N,0.5273778531423069,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5032688835341262,
AH2018_LFQ_2_X,0.5215847026691932,
PG2020_Intensity 2h_B,0.4468501390877588,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.4722928136690801,
GF2025_P3_Sph,0.46975270872036806,
DB2022_LFQ intensity L2,0.46054069232903494,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.47369965624977034,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.45672416399016363,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5121852276885727,
ZQ2022_N1,0.4887359590416631,
LY2019_P6-,0.46132039144442993,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,0.5214387335547039,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.4821974520034698,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,0.4762517364718608,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.4703730539748306,
SR2019_BT549_Biol_repl_2,0.4825385951359311,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,0.46266632288800547,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.4741742746360778,0.9586919820656756
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5180438956197877,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.47475530865476046,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,0.49095797186193213,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.4648502802641891,
EJN2021_4_Ex_Ins,0.46455713984416186,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.4774665713346448,
EP2017_Pervanadate R#3 log2 ratio,0.48438411974285206,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.519776976968826,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,0.4574333653322305,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,0.47640143747835567,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.4775036811543869,
LY2019_P3-,0.4548814235853674,
FR2021_Intensity.A,0.5031918575784308,
EJN2021_3_Ex_Ins,0.4630546572458307,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.4771101551865032,0.9646139469623548
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,0.47252666523429565,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.44982552369621537,
FS2019_Ctr3,0.5068056161004697,
WZ2023_Pu_025_20min,,0.95634119317398
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.4935593831178377,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,0.46344180744266694,
FR2021_Norm.Intensity.N,0.505433233952461,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.4699955889300999,
RB2022_4_PreSprint,,
DB2022_Intensity R2,0.47016235927586236,
AH2018_TMTMS2_Pool,0.4783196539830805,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.47638679135542983,
LY2019_P8+,0.519836462626047,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,0.47966697291101273,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.47924463472888257,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.46194691932348436,
LY2019_P2-,0.4660264779590051,
AH2018_LFQ_IT_1_X,0.4813443161521558,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.48679756623360587,0.9709720525676798
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.45391387136282696,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.47478267583358363,
SR2019_MCF10A_Biol_repl_4,0.4702226539598473,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.4645379592534377,
HS2024_5_B_T2,,
HS2024_6_I_T1,0.4834106007484858,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.4823947547833467,
AH2018_TMTMS3_3_N,0.47605372571608795,
SR2019_HCC1419_Biol_repl_2,0.4718606043945182,
FR2021_Intensity.N,0.5054271254818539,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.41042954600744386,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.4904392185162485,
KBE2022_Log2_Ex_36_T,0.4822433434949433,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.4752445152292182,0.9590420188614972
KS2014_Intensity C2,0.4707829820936535,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.47533652331444354,
CK2022_9 200-1,0.49579970624388364,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,0.4541330682254124,
CK2022_10 200-1,0.49636823856100004,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.48784885910405057,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5116326385790816,
HS2024_3_I_T3,0.4524716644950037,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5029449234092161,
ZQ2022_C3,0.4477415778269842,
EJN2021_3_Rest_Ins,0.4560980638888103,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.4834532660702364,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.4677478663999654,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.47624071712140165,0.961443332220754
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,0.48930023967954983,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.49300901272040193,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5262649570278708,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.467381706421882,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.523316201954582,
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,0.46347828243642136,
AR2021_KD 48h,0.4481799344810758,
FR2021_Intensity.B,0.5076500134980916,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,0.4709852661430609,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,0.48128279761527804,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.4718164637332885,0.9709771930604996
KBE2022_Log2_Ex_29_U,0.4775301149849411,
HS2024_7_B_T1,0.4737969690341774,
AH2018_LFQ_M_2_X,0.5235735633049198,
AH2018_LFQ_IT_4_N,0.4637609470634509,
CK2022_15 200-1,0.4961175427163511,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.4822585305605827,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.4872138865991396,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.4967381485521715,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.47372745998072796,0.9589510103530802
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.469780474544591,
KS2014_Intensity pY_E5_3,0.4588119972347677,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.4832163503984694,
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.45857246256101,
KBE2022_Log2_Ex_44_U,0.48207153527734686,
WZ2023_Pe_010_20min,0.48676319078869446,0.96464650938811
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,,
FSO2013_Ratio H/M normalized Rep3___1,0.4689405123645698,
AH2018_SILAC_M_3_C,0.4633767377454101,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5020459237813221,
AH2018_SILAC_M_2_X,0.5043173734689089,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.4740778543289141,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.4823679370150049,0.9616849391448952
PG2020_Intensity 6h_C,0.5026912833370595,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5242606818045499,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.48096904279226943,
CK2022_15 16-1,0.4765480050874684,
CK2022_3 16-1,0.4774555355055299,
LY2019_P4-,0.49564708249944206,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,0.4651837166777528,
HS2024_3_I_N2,0.4686655821671298,
GF2025_P8_Adh,0.472637996498623,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,0.47038708385910827,
GF2025_P5_Sph,0.47115129726605326,
CK2022_10 16-1,0.4749963292342471,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,0.48363726587289046,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,0.4692788034187784,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,0.4654959144401911,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4787921555519297,
EJN2021_2_Ex_Basal,0.47088424901715537,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.45179258874656797,
AR2021_L41 10 μM,0.4363492575541666,
CF2017_EOC 2,0.4394930604703496,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.47953525412535547,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,0.4690797512957046,
CK2022_6 16-1,0.47631400945175856,
ZX2022_CB treated Replicate 1,0.44337959410527783,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,0.5250602582753675,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.46782185716353125,
AR2021_L41 1 μM,0.43351950993175953,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.47757575786406564,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.44493825121561215,
KS2014_Intensity C4,0.47590042362302204,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.46781907322509314,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,0.52942197305264,
SR2019_MCF10A_Biol_repl_3,0.47795868196181934,
HS2024_7_B_T2,0.4764282040651156,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,0.48056146667811345,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5213912499450127,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.454286619355607,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.4806997935616017,
WZ2023_Pu_025_10min,0.48350169915582675,0.9675650045736538
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.47997505232703314,
SR2019_JIMT1_Biol_repl_4,0.4623178914816633,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.4640864165749094,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.48649731299588245,0.967686544616454
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.5044593887661208,
KS2014_Intensity C6,0.4732964219947107,
ZQ2022_N3,0.502620935834103,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.47240855576799823,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.4445030483946452,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,0.4742393007513075,
AH2018_SILAC_IT_2_C,0.4824638585994856,
CK2022_5 40-1,0.47716651777411084,
AH2018_LFQ_3_X,0.5259542222413692,
UK2020_UA_3,,
LY2019_P7-,0.4485259957014942,
GF2025_P5_Adh,0.45882973551494227,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,0.46665015298617485,
CR2017_Ratio Replicate 2.2,,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.4770127049434883,
ZQ2022_C1,0.46612371785716095,
CR2017_Ratio Replicate 2.1,0.48550533576702887,
PG2020_Intensity CT_B,0.4526626441376149,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.5297807418694539,
KS2014_Intensity pY_E5_1,0.46190248309724713,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,0.5299554832639565,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5192865787822346,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,0.4675254457892475,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5259821141620865,
YA2020_Reporter_intensity_Cancer_No.4,0.45589017913887453,
KS2014_Intensity pY_E5_2,0.45955497986680216,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.49356191915349634,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.4745378595257032,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,0.5049396800483114,
CK2022_14 16-1,0.4742318241400277,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.47769724806728703,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.49061900579618817,
AH2018_TMTMS2_1_X,0.4715824476327964,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,0.4763497936664683,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,0.4554299015769822,
HS2024_6_I_N2,0.46171886275814006,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.45224058207093504,
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.4813279818196656,
PG2020_Intensity 10h_B,0.4941260638673827,
AH2018_TMTMS3_1_X,0.4760876164195286,
CF2017_FTE 14,0.4559757144465863,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5099286490550407,
SR2019_HCC1419_Biol_repl_3,0.47109381975225967,
KBE2022_Log2_Ex_14_T,0.47680802833026076,
EP2017_Untreated R#2 normalized log2 ratio,0.45420315508601844,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.46281598500824556,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.48326890064562883,
AS2011_Ratio H/L Normalized RNAi_2_1,,
